Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease

Abstract

Our findings show that the time course of disease status based on UPDRS is a much better predictor of future clinical events than any baseline disease characteristic. Continued selegiline treatment appears to increase the hazard of death.